☆ 4.4 Article

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Volume 71, Issue 37, Pages 1174-1181

Publisher

Centers for Disease Control MMWR Office

DOI: 10.15585/mmwr.mm7137a3

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Publisher

Centers for Disease Control MMWR Office

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Publisher

Centers for Disease Control MMWR Office

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper